Literature DB >> 17329707

An ongoing study of anemia correction in chronic kidney disease.

Marc A Pfeffer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17329707     DOI： 10.1056/NEJMc066568

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  Use of agents stimulating erythropoiesis in digestive diseases.

Authors:  Rosario Moreno López; Beatriz Sicilia Aladrén; Fernando Gomollón García
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

Review 2.  The correction of anemia in patients with the combination of chronic kidney disease and congestive heart failure may prevent progression of both conditions.

Authors:  Donald S Silverberg; Dov Wexler; Adrian Iaina; Doron Schwartz
Journal:  Clin Exp Nephrol       Date:  2008-08-01       Impact factor: 2.801

3.  Maintaining high hemoglobin levels improved the left ventricular mass index and quality of life scores in pre-dialysis Japanese chronic kidney disease patients.

Authors:  Hideki Hirakata; Yoshiharu Tsubakihara; Fumitake Gejyo; Shinichi Nishi; Yasuhiko Iino; Yuzou Watanabe; Masashi Suzuki; Akira Saito; Takashi Akiba; Daijo Inaguma; Shunichi Fukuhara; Satoshi Morita; Michiaki Hiroe; Yoshiyuki Hada; Makoto Suzuki; Makoto Akaishi; Kazutaka Aonuma; Tadao Akizawa
Journal:  Clin Exp Nephrol       Date:  2009-09-09       Impact factor: 2.801

Review 4.  Anemia treatment in chronic kidney disease: shifting uncertainty.

Authors:  Marc A Pfeffer
Journal:  Heart Fail Rev       Date:  2008-04-10       Impact factor: 4.214

Review 5.  The role of anemia management in improving outcomes for African-Americans with chronic kidney disease.

Authors:  Janice P Lea; Keith Norris; Lawrence Agodoa
Journal:  Am J Nephrol       Date:  2008-04-24       Impact factor: 3.754

Review 6.  Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.

Authors:  Suetonia C Palmer; Valeria Saglimbene; Dimitris Mavridis; Georgia Salanti; Jonathan C Craig; Marcello Tonelli; Natasha Wiebe; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2014-12-08

7.  Recombinant human Epo treatment: beneficial in chronic kidney disease, chronic heart failure, or both? Editorial to: "Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance by Pappas et al.".

Authors:  A M S Belonje; R A de Boer; A A Voors
Journal:  Cardiovasc Drugs Ther       Date:  2008-02       Impact factor: 3.727

8.  Treating anemia of chronic kidney disease in the primary care setting: cardiovascular outcomes and management recommendations.

Authors:  Rebecca J Schmidt; Cheryl L Dalton
Journal:  Osteopath Med Prim Care       Date:  2007-10-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.